8-K - KALA BIO, Inc. | StockGist

Current Report Details

Event Type

Management Change+6 More

Disclosure

Mandatory

Variant

8-K

Items Reported

1.01

. Entry into a Material Definitive Agreement. As previously disclosed in the Current Report on Form 8-K filed with the Securities and Exchange Commission (“ SEC

Material Agreement

$6.0M$2.00$1.8M$2.00

Source Document

3.02

of this Current Report on Form 8-K, the Certificate of Designations was filed with the Secretary of State of the State of Delaware on January 30, 2026, prior to

Securities Issuance

5.01

of this Current Report on Form 8-K, pursuant to the terms of the Securities Purchase Agreement, upon the approval at the Annual Meeting of the Issuance Proposal

Corporate Governance

directors by the Board of Directors (the “ Board

5.02

of this Current Report on Form 8-K below is incorporated into this Item 5.01 by reference. Item 5.02. Departure of Directors or Principal Officers; Election of

Management Change

Company on any matters relating to the Company

5.03

. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. As described below under Item 5.07 of this Current Report on Form 8-K, at the Annual

Charter Amendment

5.07

. Submission of Matters to a Vote of Security Holders. A total of 15,489,822 shares of the Company’s Common Stock were present in person or represented by proxy

Shareholder Vote

9.01

. Financial Statements and Exhibits. (d) Exhibits Exhibit Description 3.1 Certificate of Designations, Preferences and Rights of Series AA Convertible Non-Redee

Exhibits Only

Exhibits (4)

10.1

EXHIBIT 10.1

3.1

EXHIBIT 3.1

3.2

EXHIBIT 3.2

8-K